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Abstract
Background—Dopaminergic brain circuits participate in emotional processing and impulsivity. 
The dopamine transporter (DAT1) modulates dopamine reuptake. A variable number tandem 
repeat (VNTR) in the DAT1 gene affects DAT1 expression. The influence of DAT1 genotype on 
neural activation during emotional processing and impulse inhibition has not been examined.
Methods—Forty-two healthy subjects were classified as 9DAT (n=17) or 10DAT (n=25) based 
on DAT1 genotype (9DAT=9R/9R and 9R/10R; 10DAT=10R/10R). Subjects underwent fMRI 
during non-emotional and emotional go/no-go tasks. Subjects were instructed to inhibit responses 
to letters, happy faces, or sad faces in separate blocks.
Results—Accuracy and reaction time did not differ between groups. Within group results 
showed activation in regions previously implicated in emotional processing and response 
inhibition. Between groups results showed increased activation in 9DAT individuals during 
inhibition. During letter inhibition, 9DAT individuals exhibited greater activation in right inferior 
parietal regions. During sad inhibition, 9DAT Individuals exhibited greater activation in frontal, 
posterior cingulate, precuneus, right cerebellar, left paracentral, and right occipital brain regions. 
The interaction between DAT genotype and response type in sad versus letter stimuli showed 
increased activation in 9DAT individuals during sad no-go responses in the anterior cingulate 
cortex, extending into frontal-orbital regions.
Discussion—9DAT individuals have greater activation than 10DAT individuals during neutral 
and sad inhibition, showing that genotypic variation influencing basal dopamine levels can alter 
the neural basis of emotional processing and response inhibition. This may indicate that 9R 
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carriers exert more effort to overcome increased basal dopamine activation when inhibiting 
responses in emotional contexts.
Keywords
dopamine transporter; response inhibition; emotion
INTRODUCTION
The dopamine transporter (DAT) is one determinant of dopamine availability in the brain. 
DAT participates in dopamine reuptake from the synaptic cleft and helps terminate the action 
of dopamine at neural synapses. Genetic variations in DAT availability alter the amount of 
dopamine available for neurotransmission. The DAT gene, DAT1, is located on chromosome 
5p15 and has a variable number tandem repeat (VNTR) at the 3′ end. Differences in VNTR 
length affect expression of the transporter and synaptic dopamine levels (Fuke et al. 2001). 
The most commonly studied alleles are the 9-repeat and 10-repeat alleles. 9-repeat carriers 
(9R/9R or 9R/10R genotypes) have been shown to have decreased DAT1 expression relative 
to the 10-repeat homozygotes, especially in cortico-striatal pathways (Fuke et al. 2001; Mill 
et al. 2002). Decreased DAT expression leads to increased transporters at the synapse, and a 
consequent increase in dopamine availability for neurotransmission. The effect of DAT 
expression on dopamine availability has been demonstrated in mouse studies showing that 
DAT knock-out mice exhibit hyperdopaminergia (Gainetdinov et al. 1999).
DAT is expressed abundantly and densely in the striatum at dopaminergic synapses, and 
more sparsely in cortical regions (Staley et al. 1995). Bertolino et al. (2006) postulated that 
the distribution of DAT in cortical regions—at a distance from dopaminergic synapse—
could indicate its importance in modulating the signal-to-noise ratio during activities of 
cognitive control and working memory (Bertolino et al. 2006). In this study, an emotional 
go/no-go paradigm combining the cognitive processes of emotional procession, impulse 
control, and working memory is used to examine the influence of DAT expression on 
activation in these areas.
Dopamine modulates many aspects of cognition, emotional processing, and impulse control 
(Garcia-Garcia et al. 2010; Badgaiyan et al. 2009; Sevy et al. 2006; Ramdani et al. 2015; 
Takahashi et al. 2005). DAT1 genotype has been implicated as a risk factor for psychiatric 
disorders including attention deficit hyperactivity disorder (ADHD), obsessive-compulsive 
disorder (OCD), and bipolar disorder (BD). In clinical populations, the 10R/10R genotype 
has been associated with cognitive endophenotypes including reduced selective attention and 
inhibition, depressive disposition, and decreased cognitive flexibility (Cornish et al. 2005; 
Felten et al. 2011; Mata et al. 2012; Garcia-Garcia et al. 2010). Many studies have examined 
the influence of DAT1 genotype on cognitive task performance and neural activation in 
ADHD and other clinical populations, but few have examined how DAT1 genotype 
modulates cognition and emotional processing in healthy individuals. Because DAT1 may 
signal cognitive endophenotypes associated with psychiatric disorders, it is important to 
understand how dopamine activity modulates the neural circuits underlying these processes 
in healthy populations.
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Dopamine has been shown to influence neural activation during both emotional processing 
and impulse control in healthy individuals. Takahashi et al. (2005) demonstrated that 
dopamine depletion attenuated activation in components of the limbic-cortico-striatal-
pallidal-thalamic circuit and amygdala in response to unpleasant stimuli (Takahashi et al. 
2005). Ramdani et al. (2015) showed that dopamine precursor depletion led to less 
proficiency during a Simon task, without affecting basal impulse activation during the task 
(Ramdani et al. 2015). Based on these results, it is unclear whether 9R carriers are at a 
disadvantage during emotional inhibition. They may exhibit greater activation in response to 
emotional stimuli, but also be better able to inhibit that activation due to greater dopamine 
availability.
Previous studies additionally show some evidence that DAT1 genotype influences cognition 
and behavior in healthy adults. Increased dopamine availability in 9R carriers has been 
associated with better working memory plasticity, decreased impulsivity, and decreased risk-
taking behavior (Mata et al. 2012; Brehmer et al. 2009; Bertolino et al. 2006). These results 
are contrary to studies showing that artificially elevated dopamine levels (such as during 
amphetamine use or dopamine replacement therapy) impair impulse inhibition and enhance 
responses to emotional stimuli. For example, Ondo et al. (2008) surveyed a group of 300 
patients taking dopamine for either Parkinson’s disease or restless legs syndrome and found 
that 19.7% of subjects experienced more impulsivity while on dopamine therapy (Ondo et al. 
2008). Additionally, gene deletion studies show that DAT knockout mice exhibit 
hyperactivity and impaired sensorimotor gating in prepulse inhibition of the startle response 
(Gainetdinov et al. 1999; Ralph et al. 2001).
One possibility is that greater baseline activation in dopamine pathways would necessitate a 
larger inhibitory response during impulse inhibition to achieve equal or better performance 
in impulse inhibition paradigms. If greater inhibitory activation is achieved, performance is 
not impaired. Caldu et al. (2007) demonstrated that healthy subjects who were homozygous 
for the 9R allele, as well as homozygous for the Val allele of the catechol-o-
methyltransferase (COMT) gene, showed the highest activation to achieve the same level of 
performance as 9R heterozygotes and 10R homozygotes during an N-back working memory 
task (Caldu et al. 2007). This could mean that 9R carriers have basal dopamine levels that 
are too high for optimal performance without appropriately increased activation to modulate 
cognitive processes. The increased activation reflects the possibility that 9R carriers have a 
harder time modulating their response to stimuli in cognitive tasks.
Given the role of dopamine in impulsivity and emotional response, it is important to assess 
the influence of dopamine availability on behavioral inhibition and emotional processing. 
The go/no-go task measures impulse control by assessing the ability to inhibit a prepotent 
response. Subjects are asked to respond rapidly to “go” cues and withhold a response to “no-
go” cues. Cues are typically neutral. Replacement of neutral cues with faces conveying 
positive (happy) or negative (sad) emotion creates an emotional go/no-go task that allows the 
study of response inhibition in a contrasting emotional context. Shafritz et al. (2006) 
demonstrated that response inhibition in an emotional context recruits different brain areas 
than response inhibition in a non-emotional context. A non-emotional go/no-go task, in 
which the stimuli were letters, recruited brain areas associated with motor control and 
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inhibition including the basal ganglia (BG), anterior cingulate cortex (ACC), dorsolateral 
prefrontal cortex (DLPFC), and pre-supplementary motor area (pSMA). The addition of 
emotional valence to the task recruited additional limbic and paralimbic brain regions 
including the left inferior posterior parietal cortex (PPC), posterior inferior frontal cortex 
(PFC), and subgenual anterior cingulate cortex (sACC) (Shafritz et al. 2006).
In this study, we use an emotional go/no-go task (Shafritz et al. 2006) among healthy 
individuals to examine the effects of DAT1 genotype on performance and neural activation. 
We predict that during emotional inhibition, 9R carriers will have stronger BOLD signals in 
regions implicated in impulse inhibition, including the DLPFC, basal ganglia, and 
sensorimotor regions. Additionally, we predict that 9R carriers will have greater activation in 
limbic and paralimbic regions related to emotional processing during emotional inhibition 
than during letter inhibition.
METHODS
Subjects
46 healthy subjects (24 women) age 18–60 years were recruited via advertisement. Subjects 
had no self-reported personal or family history of psychiatric illness, neurologic illness, or 
substance abuse. Subjects denied alcohol use within a week of the scan session and did not 
have a positive urinary toxicology screening at baseline. All subjects signed an informed 
consent form approved by the local Institutional Review Board and were paid $75 for 
screening and $75 for the magnetic resonance imaging scan. Subjects were classified as 
9DAT or 10DAT individuals based on their DAT1 genotype. 9DAT individuals were 
homozygous or heterozygous for the 9-repeat allele (9R/9R or 9R/10R). 10DAT individuals 
were homozygous for the 10-repeat allele (10R/10R).
Functional Magnetic Resonance Imaging Procedure
Images were acquired using a 3T Tim Trio scanner (Siemens, Erlangen, Germany). 
Participants underwent a high-resolution three-dimensional magnetization prepared rapid 
acquisition gradient-echo scan. The high-resolution (1.0 × 1.0 × 1.2 mm3 voxels) anatomical 
volume was comprised of 160 sagittal slices. Functional images were acquired with T2*-
weighted gradient-echo planar imaging sequences sensitive to blood oxygen level-dependent 
(BOLD) contrast (129 measurements, repetition/echo time 2250/29 msec, 39 slices to cover 
whole brain, field of view 220 × 220 mm; 2.5 × 2.5 × 3.5 mm3 voxels). An integrated 
parallel acquisition technique reduction factor of 2 was implemented with a generalized 
autocalibrating partially parallel acquisition to improve spatial resolution and to reduce 
geometric distortion and scan time.
Task Description
Participants were trained on the go/no-go task before their scan. Task design was identical to 
that described by Shafritz et al. using the Ekman and Friesen Pictures of Facial Affect 
(Shafritz et al. 2006). Go and no-go blocks were alternated between beginning and ending 
fixation blocks. There were two go and no-go blocks each for sad faces, happy faces, and 
letters. During go blocks, participants were directed to press a button for each face or letter 
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presented. Go blocks consisted of only a single stimulus type (happy face, sad face, or 
letter). During no-go blocks, subjects were instructed to press a button for go trials (targets) 
but to withhold a response for no-go trials (nontargets). No-go blocks consisted of 6 no-go 
and 12 go stimuli. For the inhibition of sad faces (sad no-go), subjects were instructed to 
press only for happy faces and withhold pressing for sad faces. For the inhibition of happy 
faces (happy no-go), subjects were instructed to press only for sad faces and withhold 
pressing for happy faces. For the non-emotional condition (letter no-go), subjects were 
instructed to withhold a response only for the letter X. Each block had 12 trials. Stimuli 
were presented for 500 msec, followed by a black screen for 1000 msec to record the 
response. An instruction screen was shown for 2.25 seconds before each condition.
Genotyping
Genomic DNA was extracted from fresh blood samples using a standard protocol (Lahiri 
and Nurnberger 1991). Genotyping of the SLC6A3 40 bp repeat polymorphism 
(rs28363170) was performed as previously described by Vandenberge et al. (1992). 
Amplification products were separated by agarose gel electrophoresis. Product sizes were 
determined by comparison to molecular weight standards and known sequenced samples.
Behavioral Analysis
Go and no-go accuracy scores and go reaction times were compared via a one-way analysis 
of variance (ANOVA) with IBM SPSS Statistics, Release 21.0 (IBM, Armonk, New York) to 
examine potential performance differences between groups.
Image Analysis
Imaging data were preprocessed and analyzed with standard procedures using Statistical 
Parametric Mapping software (SPM, Wellcome Trust Centre for Neuroimaging, London, 
United Kingdom; http://www.fil.ion.ucl.ac.uk/spm). No subject included had head 
movement exceeding 2 mm of translation of 2° rotation in any direction. The six motion 
parameters were also used as covariates in the analysis to account for residual motion 
confounds.
Functional images were aligned and co-registered to the structural magnetization prepared 
rapid acquisition gradient-echo volume. Functional images were normalized to a standard 
Montreal Neurological Institute (MNI) template with 2 mm isotropic voxels then smoothed 
with a 8 mm full-width at half maximum Gaussian kernel. Individual analyses were 
performed using a delayed boxcar function convolved with each stimulus type (fixation, 
instructions, and conditions) to create a general linear model to model the BOLD response. 
A beta coefficient was calculated for each condition of interest (happy go, happy no-go, sad 
go, sad no-go, letter go, letter no-go, rest) that reflected its contribution to the BOLD time 
series.
To analyze brain activation during response inhibition, no-go responses were contrasted with 
go responses for each subject. Only correct responses were included. The contrast for each 
emotional no-go condition was the go condition of the same valence (e.g., happy no-go 
versus. happy go). For example, in happy no-go – happy go, both blocks present emotional 
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stimuli to the subject. However, because happy no-go has the additional requirement of 
inhibiting responses to happy faces, the contrast of happy no-go – happy go is assumed to 
reflect the emotional inhibition process.
Using the contrasts form responses inhibition, two sample t-tests controlling for age and 
gender were conducted to look at the group differences between 10DAT and 9DAT in each 
response inhibition. Full factorial analysis with age and gender as covariates was run to 
analyze the interaction between DAT group and condition (emotional inhibition versus letter 
inhibition) separately for happy inhibition versus letter inhibition and sad inhibition versus 
letter inhibition. From these t-tests and full factorial models, significant clusters were 
identified using the Automated Anatomical Labeling (AAL) atlas (Tzourio-Mazoyer et al. 
2002). A whole-brain gray matter mask was used in the second level analysis. Monte Carlo 
simulations using AFNI (Cox 1996) software program 3dClustSim (http://
afni.nimh.nih.gov/pub/dist/doc/program_help/3dClustSim.html) was utilized to determine 
the culsterwise significance. At least 219 contiguous voxels significant at p=0.01 were 
required for identifying a cluster as significant at p=0.05(corrected) cluster-wise significance 
level. To visualize the between group differences, the beta coefficients were extracted from 
the significant clusters of the second level analysis (see Table 2) and were used to make the 
boxplots in SPSS 21.
RESULTS
Subjects
42 subjects were included in the analysis. Four subjects were eliminated due to unknown 
genotype (1) and a family history of psychiatric disorder (3). Subjects were between the ages 
of 21 and 58 (mean: 31.5, SD: 10.3). Age did not differ between 9DAT and 10DAT groups. 
Subjects identified as Caucasian (38), Asian (1) or African-American (3). Ethnic distribution 
did not differ significantly between 9DAT and 10DAT groups. The 10DAT group had 25 
subjects. The 9DAT group had 17 subjects.
Behavioral Results
Groups did not differ on response time and accuracy measures. See supplemental Table 1 for 
performance measures.
Imaging Within-Group Results
See Supplemental Table 1 for within-group results. Both 9DAT and 10DAT groups exhibited 
brain activation primarily in frontal, temporal, and occipital brain regions, in addition to 
limbic and motor areas. These results are in line with previous studies examining activation 
during emotional and inhibitory tasks (Shafritz et al. 2006; Britton et al. 2006).
Imaging Between-Group Results
Letter Inhibition—A main effect of DAT group was present in the right inferior parietal 
cortex during the letter no-go condition. The 9DAT group exhibited higher parietal cortex 
activation compared to the 10DAT group (Figure 1, Table 2).
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Happy Face Inhibition—There was no difference in activation between 9DAT and 
10DAT groups during happy inhibition.
Sad Face Inhibition—A main effect of DAT group was present in the left and right PCC 
and precuneus, right cerebellum, right inferior and middle occipital, left paracentral lobule, 
and superior frontal regions. Post hoc results showed increased activation throughout these 
areas in the 9DAT group compared to the 10DAT group (Figure 2, Table 2).
Happy and Letter Interaction—There was no interaction between DAT group and 
response type on neural activation during happy versus letter inhibition.
Sad and Letter Interaction—There was an interaction between DAT group and 
condition on neural activation during response inhibition. During inhibition of emotional 
stimuli, the 9DAT group exhibited greater activation in the left rostral ACC (pregenual and 
subgenual), extending into superior medial frontal and medial orbital regions compared to 
the 10DAT group. This effect was not seen during inhibition of neutral stimuli (Figure 3, 
Table 2).
DISCUSSION
This investigation is the first to study neural activation during an emotional response 
inhibition task across different DAT1 genotypes in healthy individuals. This study attempted 
to examine the differences in neural activation during emotional inhibition that result from 
genetically determined differences in dopamine availability.
Overall, 9DAT individuals exhibited greater activation across all contrasts measured in this 
study. Increased neural activation during emotional response inhibition could indicate that 
9DAT individuals must put forth more effort to inhibit emotional responses. In this study, 
9DAT individuals had the same accuracy and reaction time as 10DAT individuals, indicating 
that they required more activation to achieve the same performance in an emotional response 
inhibition task. This has implications for the effect of increased dopamine availability on 
impulsive behavior. The present results show that increased dopamine availability—
classically associated with increased impulsivity—does not necessarily impair response 
inhibition if inhibitory brain circuits are sufficiently active. Previous studies examining the 
influence of Levodopa infusion on go/no-go performance in subjects exhibiting symptoms of 
Tourette’s syndrome support this finding. Hershey et al. (2004) showed that infusion of the 
drug Levodopa resulted in greater activation during a neutral go/no-go task (Hershey et al. 
2004). The Levodopa did not alter the performance of subjects, just as DAT genotype did not 
alter performance in the present study. This could have implications in examining the 
threshold at which dopaminergic disorders, such as Parkinson’s disorder, begin to impair 
cognition and emotional processing.
Further studies examining the effects of dopamine levels on performance in more complex 
emotional inhibition tasks must be performed to determine whether 9DAT individuals have 
increased dopamine availability and, in turn, whether increased dopamine availability makes 
impulse inhibition more difficult. It could be useful to measure dopamine availability 
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directly instead of DAT1 expression, using a joint PET and fMRI study. Alternatively, 
increasing dopamine release in healthy populations, as previously done in bipolar 
populations, could help determine whether increased dopamine availability impairs 
performance on impulse inhibition tasks (Anand et al. 2000). In addition, COMT genotype 
has been shown to interact with DAT genotype to influence performance in cognitive tasks 
(Caldu et al. 2007). Caldu et al. (2007) found significant interactions between DAT and 
COMT genotype in working memory function and activation in cortical regions implicated 
in working memory function, but did not find an independent effect of DAT genotype on 
these measures. COMT genotype was not recorded in this study, making it difficult to isolate 
the effects of DAT genotype on performance in the emotional go/no-go task. In future 
studies, COMT and DAT genotype should be recorded and interactions analyzed to isolate 
the effects of genotypic variation in COMT and DAT expression.
9DAT individuals had increased activation in the parietal cortex during inhibition of non-
emotional stimuli. The parietal cortex has been previously implicated in go/no-go tasks as a 
region that is active during inhibition of prepotent responses (Goldstein et al. 2007; 
Watanabe et al. 2002). These findings support the role of the parietal cortex in response 
inhibition.
No group differences were observed during happy face inhibition. This is contrary to 
previous studies showing that 9R carriers have more robust activation in response to reward-
inducing stimuli, which would, in turn, require greater activation for adequate inhibition 
(Dreher et al. 2009).
During sad face inhibition, the 9DAT carriers had increased activation in the left and right 
posterior cingulate cortex (PCC) and precuneus, superior frontal and medial frontal areas, 
cerebellum, temporal pole, occipital areas, and the left paracentral and lobule. The 
cerebellum and occipital areas have well-established roles in coordination of motor activity 
and emotional picture processing, respectively (Phan et al. 2002; Lotze et al. 1999). The 
emotional go/no-go task requires motor and visual processing, and it is expected that these 
areas would show activation. The PCC has been implicated in evaluative processing of 
emotional stimuli, specifically in the identification of and response generation to emotional 
stimuli (Bush et al. 2000). This finding has not been previously demonstrated during an 
emotional go/no-go paradigm, and suggests an important role of the PCC in intrinsic control 
during emotional tasks. The precuneus has not previously been shown to be active during 
emotional impulse inhibition and warrants further investigation. Though the inferior frontal 
gyrus has been shown to be crucial for stop-signal inhibition in previous studies, the superior 
frontal and mid-area have not been shown to influence inhibition (Aron et al. 2003). Further 
studies are needed to confirm this finding and delineate the function of these areas.
When combining sad and letter inhibition, the 9DAT group had increased activation in the 
ACC during inhibition of emotional faces relative to 10DAT individuals. The ACC has been 
previously implicated both in behavioral inhibition as an area that is activated when a 
prepotent response must be updated to avoid making a mistake, and in the emotional 
processing of sad faces (Shafritz et al. 2006; Hester et al. 2007). The results presented 
corroborate both of these potential roles for the ACC. Activation spread into superior medial 
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frontal and medial orbital areas, approaching orbitofrontal areas. This supports previous 
results showing that the OFC is active during impulse inhibition.
One limitation of this study is the small sample size of healthy individuals used, and the 
uneven distribution of 9DAT and 10DAT individuals. Future investigations should attract a 
larger number of participants and compare equal numbers of 9DAT and 10DAT individuals.
Another limitation of this study is the simplicity and design of the task administered. The 
go/no-go task was analyzed as a block-design, but may be better characterized as an event-
related design. The go/no-go task has been considered to be a mixed block- and event-
related design (Rubia et al. 2001). Additionally, the comparison of faces to letters may not 
be adequate in distinguishing emotional responses. Future studies could compare inhibition 
during exposure to emotional faces and neutral faces to control for the difference between 
letters and human faces. This could better isolate the influence of emotional processing on 
behavioral inhibition.
Despite these limitations, this study provides evidence for DAT1 genotype-modulated 
differences on emotional response inhibition in healthy individuals. We conclude that 9DAT 
individuals, as a result of greater basal dopamine availability, exhibit more activation in 
response to emotional stimuli and, as a result, more effortful impulse inhibition. These 
findings need to be replicated and investigated further in future studies.
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Figure 1. Difference between 10DAT and 9DAT Group Activation for the Letter No-go>Letter 
Go Condition
Figure 1 shows the differences between 10DAT (homozygous for 10-repeat allele, 10R/10R) 
and 9DAT (homozygous or heterozygous for 9-repeat allele, 9R/9R or 9R/10R) in the letter 
no-go > letter go condition. The statistical significance threshold for examining this effect 
was set at p=0.01 and a cluster size of 219 voxels corresponded to a corrected p=0.05. Here, 
the 9DAT group shows more activation in the right inferior parietal area than the 10DAT 
group.
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Figure 2. Difference between 10DAT and 9DAT Group Activation for the Sad No-go>Sad Go 
Condition
Figure 2 shows the difference between 10DAT and 9DAT groups activation for sad no-go > 
sad go condition. The statistical significance threshold for examining this effect was set at 
p=0.01 and a cluster size of 219 voxels corresponded to a corrected p=0.05. (A) Left 
paracentral lobule, 9DAT>10DAT. (B) Right middle-inferior occipital, 9DAT>10DAT. (C) 
Left & Right PCC-precuneus, 9DAT>10DAT. (D) Left superior frontal and left & right 
superior medial frontal, 9DAT>10DAT.
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Figure 3. Interaction between Groups (10DAT, 9DAT) and Conditions (Sad No-go > Sad Go, 
Letter No-Go > Letter Go)
Figure 3 shows the interaction between the sad emotion and non-emotional conditions 
between the 9DAT and 10DAT groups, the significance thershold for examining this this 
interaction was set at p=0.05 and a cluster size of 935 voxels corresponded to cluster-wise 
corrected p=0.05. The resultant area was the left ACC extending into the superior medial 
frontal and medial orbital areas.
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